Literature DB >> 23560475

Failure mode and effect analysis in blood transfusion: a proactive tool to reduce risks.

Yao Lu1, Fang Teng, Jie Zhou, Aiqing Wen, Yutian Bi.   

Abstract

BACKGROUND: The aim of blood transfusion risk management is to improve the quality of blood products and to assure patient safety. We utilize failure mode and effect analysis (FMEA), a tool employed for evaluating risks and identifying preventive measures to reduce the risks in blood transfusion. STUDY DESIGN AND METHODS: The failure modes and effects occurring throughout the whole process of blood transfusion were studied. Each failure mode was evaluated using three scores: severity of effect (S), likelihood of occurrence (O), and probability of detection (D). Risk priority numbers (RPNs) were calculated by multiplying the S, O, and D scores. The plan-do-check-act cycle was also used for continuous improvement.
RESULTS: Analysis has showed that failure modes with the highest RPNs, and therefore the greatest risk, were insufficient preoperative assessment of the blood product requirement (RPN, 245), preparation time before infusion of more than 30 minutes (RPN, 240), blood transfusion reaction occurring during the transfusion process (RPN, 224), blood plasma abuse (RPN, 180), and insufficient and/or incorrect clinical information on request form (RPN, 126). After implementation of preventative measures and reassessment, a reduction in RPN was detected with each risk. The failure mode with the second highest RPN, namely, preparation time before infusion of more than 30 minutes, was shown in detail to prove the efficiency of this tool.
CONCLUSIONS: FMEA evaluation model is a useful tool in proactively analyzing and reducing the risks associated with the blood transfusion procedure.
© 2013 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2013        PMID: 23560475     DOI: 10.1111/trf.12174

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  11 in total

1.  Quality improvement methodologies increase autologous blood product administration.

Authors:  Ashley B Hodge; Thomas J Preston; Jill A Fitch; Sheilah K Harrison; Diane K Hersey; Kathleen K Nicol; Aymen N Naguib; Patrick I McConnell; Mark Galantowicz
Journal:  J Extra Corpor Technol       Date:  2014-03

2.  Application of failure mode and effect analysis in laparoscopic colon surgery training.

Authors:  Francisco Alba Mesa; Miguel Angel Sanchez Hurtado; Francisco Miguel Sanchez Margallo; Virginia Gomez Cabeza de Vaca; Andrzej L Komorowski
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

3.  Using the failure mode and effects analysis model to improve parathyroid hormone and adrenocorticotropic hormone testing.

Authors:  Racheli Magnezi; Asaf Hemi; Rina Hemi
Journal:  Risk Manag Healthc Policy       Date:  2016-12-01

4.  Evaluating the application of failure mode and effects analysis technique in hospital wards: a systematic review.

Authors:  Hoori Asgari Dastjerdi; Elahe Khorasani; Mohammad Hossein Yarmohammadian; Mahdiye Sadat Ahmadzade
Journal:  J Inj Violence Res       Date:  2017-01-01

5.  Preventing blood transfusion failures: FMEA, an effective assessment method.

Authors:  Zhila Najafpour; Mojtaba Hasoumi; Faranak Behzadi; Efat Mohamadi; Mohamadreza Jafary; Morteza Saeedi
Journal:  BMC Health Serv Res       Date:  2017-06-30       Impact factor: 2.655

6.  Health preparedness plan for dengue detection during the 2020 summer Olympic and Paralympic games in Tokyo.

Authors:  Naoki Yanagisawa; Koji Wada; John D Spengler; Ramon Sanchez-Pina
Journal:  PLoS Negl Trop Dis       Date:  2018-09-20

7.  Blood components requests at an orthopedic hospital: a critical survey.

Authors:  Aline Cury Borchardt; Fernanda Azevedo-Silva; Luiz de Melo Amorim Filho
Journal:  Hematol Transfus Cell Ther       Date:  2019-04-23

8.  Application of failure mode and effect analysis in managing catheter-related blood stream infection in intensive care unit.

Authors:  Xixi Li; Mei He; Haiyan Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Revised Risk Priority Number in Failure Mode and Effects Analysis Model from the Perspective of Healthcare System.

Authors:  Fatemeh Rezaei; Mohmmad H Yarmohammadian; Abbas Haghshenas; Ali Fallah; Masoud Ferdosi
Journal:  Int J Prev Med       Date:  2018-01-29

10.  Benefits of VISION Max automated cross-matching in comparison with manual cross-matching: A multidimensional analysis.

Authors:  Hee-Jung Chung; Mina Hur; Sang Gyeu Choi; Hyun-Kyung Lee; Seungho Lee; Hanah Kim; Hee-Won Moon; Yeo-Min Yun
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.